Biotricity, a remote patient monitoring company, has launched a cardiac monitoring pilot program with a prominent hospital group with 60 sites across multiple states in the US.
The pilot program will allow the hospital group to test Biotricity's remote cardiac monitoring solutions. This partnership aims to evaluate the effectiveness and potential benefits of Biotricity's technology in monitoring patients with cardiac conditions in diverse healthcare settings, potentially improving patient outcomes and reducing healthcare costs.
Analyst QuickTake: Biotricity is steadily expanding its remote patient monitoring technologies. In April 2024 , it partnered with two home-based neurology and sleep apnea diagnostic companies to enhance its cardiac diagnostics services. In June 2024 , Biotricity launched a D2C heart health screening program.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.